BridgeBio Pharma News

BridgeBio Pharma | 10-Q: Quarterly report

May 3 04:31

BridgeBio Pharma | 8-K: BridgeBio Pharma Reports First Quarter 2024 Financial Results and Business Update

May 2 19:33

BridgeBio Pharma | DEFA14A: Others

Apr 26 10:17

BridgeBio Pharma | ARS: Annual Report to Security Holders

Apr 26 04:14

BridgeBio Pharma | DEF 14A: Definitive information statements

Apr 26 04:07

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Kumar Neil

Mar 15 04:05

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer STEPHENSON BRIAN C

Mar 15 04:05

BridgeBio Pharma | 424B5: Prospectus

Mar 7 06:21

BridgeBio Pharma | 8-K: Current report

Mar 7 06:16

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director Scott Randal W.

Mar 6 05:05

BridgeBio Pharma | 424B5: Prospectus

Mar 5 06:51

BridgeBio Pharma | 8-K: Current report

Mar 4 20:05

BridgeBio Pharma | 10-K: Annual report

Feb 23 05:33

BridgeBio Pharma | 8-K: BridgeBio Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update

Feb 22 20:36

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Kumar Neil

Feb 22 11:41

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director HOMCY CHARLES J

Feb 22 05:07

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer STEPHENSON BRIAN C

Feb 22 05:07

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director Valantine Hannah

Feb 21 05:04

BridgeBio Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-NEIL KUMAR(5.59%)

Feb 17 08:17

BridgeBio Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 16 05:11